News

TMR : Global Protein Glutamine Gamma Glutamyltransferase 2 Pipeline Review, H1 2019 Market Research Available at The Market Reports

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) – Transglutaminase 2 (TG2) is a member of the transglutaminase family that catalyzes calcium-dependent posttranslational modification of proteins by inserting highly stable isopeptide bonds between polypeptide chains or by conjugating polyamines to proteins. TG2 also exhibits GTPase activity and can serve as a signal-transduction G protein.

Report Source: https://www.themarketreports.com/report/protein-glutamine-gamma-glutamyltransferase-2-tissue-transglutaminase-or-transglutaminase-c-or-transglutaminase-h-or-transglutaminase-2-or-tgase-c-or-tgase-h-or-tgm2-or-ec-23213-pipeline-review-h1

Scope

  • The report reviews Protein Glutamine Gamma Glutamyltransferase 2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Protein Glutamine Gamma Glutamyltransferase 2 targeted therapeutics and enlists all their major and minor projects
  • The report assesses Protein Glutamine Gamma Glutamyltransferase 2 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Protein Glutamine Gamma Glutamyltransferase 2 targeted therapeutics

Purchase this report at: https://www.themarketreports.com/report/buy-now/1488132

List of Tables

  • Number of Products under Development by Stage of Development, H1 2019
  • Number of Products under Development by Therapy Areas, H1 2019
  • Number of Products under Development by Indication, H1 2019
  • Number of Products under Development by Companies, H1 2019
  • Products under Development by Companies, H1 2019
  • Number of Products under Investigation by Universities/Institutes, H1 2019
  • Products under Investigation by Universities/Institutes, H1 2019
  • Number of Products by Stage and Mechanism of Actions, H1 2019
  • Number of Products by Stage and Route of Administration, H1 2019
  • Number of Products by Stage and Molecule Type, H1 2019
  • Pipeline by Catabasis Pharmaceuticals Inc, H1 2019
  • Pipeline by Zedira GmbH, H1 2019
  • Dormant Projects, H1 2019

Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1488132